Developer docs
API playgroundTry for free, no card

Search company profiles

Nova Laboratories

Full company profile

uuid0008odb

Namestring
Nova Laboratories
Legal namestring
Nova Laboratories Ltd
Websiteurl
novalabs.co.uk
Company typeenum
Private
Founded yearint
1994
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersWigston, United Kingdom
HQ citystring
Wigston
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
sterile pharmaceutical manufacturing, aseptic contract manufacturing, specials medicines compounding, drug stabilisation technologies, specialty pharmaceutical products
Industry5 codes
PRIMARYHLAGABAH
Sterile Fill-Finish & Aseptic Manufacturing CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAK
Clinical Trial Material (CTM) Manufacturing & Supply CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGAGAF
Analytical Development & QC Testing (Release/Stability/Potency)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAGADAC
Release Testing & Batch Certification (QC)
SECONDARYHLAAACAJ
Gene Therapy Vector Manufacturing & CDMO Services
Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)
NAICS code3 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Medical and Diagnostic Laboratories62151
SIC code3 codes
  • Pharmaceutical Preparations2834
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
Product category
Sterile Pharmaceutical Manufacturing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Contract Manufacturing Services
TypeProfessional Services
Description

Provides contract sterile manufacturing, fill/finish, and 'Specials' manufacturing services to pharmaceutical, biopharmaceutical, and medical device companies. Includes 'turnkey' solutions with in-house analytical and microbiological testing, clinical trial labelling and packaging, and QP release.

novalabs.co.uk
2Nova Licensed Products
TypeLicensing Royalties
Description

Develops, manufactures, and distributes Nova-branded medicines for niche and rare diseases with Marketing Authorisations in UK, EU, USA and ROW. Includes liquid versions of existing medicines for precision dosing and paediatrics.

novalabs.co.uk
3'Specials' Medicines
TypeOne Time License
Description

Formulates, compounds, and packages bespoke 'Specials' medicines tailored to patients with clinically complex medical conditions. Supplies to NHS, healthcare providers, and veterinary sector.

novalabs.co.uk
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Nova Laboratories is a pharmaceutical manufacturer providing contract sterile manufacturing services (aseptic fill/finish, spray drying, clinical trial manufacturing) to pharmaceutical, biopharmaceutical and medical device companies, alongside its own Nova-branded licensed medicines for niche and rare diseases and bespoke 'Specials' compounding for individual patient needs. Its proprietary HydRIS® and VitRIS® platforms stabilise temperature-sensitive APIs, supported by in-house QC testing, microbiological services, clinical trial labelling/packaging and QP release.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Routine liquid fill/finish from small hand-filled batches to semi-automated batches of up to 10,000 vials
+3 more records
Product overview1 text field

Nova Laboratories is a diversified pharmaceutical manufacturing company offering four interconnected service/product areas: Nova Licensed Products (proprietary branded medicines for niche and rare diseases), Sterile Manufacturing (contract aseptic manufacturing including fill/finish and spray drying), 'Specials' Manufacturing (bespoke medicines for individual patient needs), and Stabilisation Technologies (HydRIS® and VitRIS® platforms for temperature-sensitive products). The company operates as both a contract manufacturer and a product developer, with capabilities spanning from early-phase clinical trials through to commercial-scale production.

Product and service5 records
1Nova Licensed Products
CategoryPharmaceutical products
Description

Nova-branded medicines for the treatment of niche and rare diseases, including liquid versions of existing medicines for precision dosing and paediatrics, with Marketing Authorisations in the UK, EU, USA and ROW. Targeted at healthcare providers, community pharmacies, and patients with rare diseases.

2Sterile Manufacturing (Contract Aseptic Manufacturing Services)
CategoryContract manufacturing services
Description

Contract aseptic manufacturing services for pharmaceutical, biopharmaceutical and medical device companies, covering routine fill/finish from small hand-filled batches to semi-automated batches of up to 10,000 vials, spray drying, and processing of complex products including small molecules, peptides, proteins, antibodies, live biologicals, and gene therapies. Includes 'turnkey' solutions with in-house analytical and microbiological testing, clinical trial labelling and packaging, and QP release.

3'Specials' Manufacturing
CategoryBespoke pharmaceutical compounding services
Description

Bespoke 'Specials' medicines formulated, compounded, and packaged to the needs of patients with clinically complex medical conditions. Includes solutions, suspensions, mixtures, creams, ointments, lotions, capsules, suppositories, enemas, nasal drops, cytotoxic products, and controlled drugs. Supplied to NHS hospitals, healthcare providers, the veterinary sector, and via Nova Laboratories Ireland for EU customers.

4HydRIS® Stabilisation Platform
CategoryDrug stabilisation technology platform
Description

Proprietary Hypodermic Rehydration Injection System that dries a formulated solution or suspension of an unstable API around filaments of a small section of filter membrane to create ultra-thin sheaths and webs of dried, stabilised product, enabling dramatic increase in thermal stability with single-action reconstitution and injection. Used for low volume injectables including vaccines, live viral and bacterial products.

5VitRIS® Stabilisation Platform
CategoryDrug stabilisation technology platform
Description

Proprietary Vitrified Readily Injectable Suspension platform using aseptic spray drying to produce thermo-stable spherical particles of a formulated solution or suspension of an unstable API. Particles can be engineered to match the density of a non-aqueous injectable vehicle for stable suspension, addressing thermal instability and storage challenges for temperature-sensitive medicines.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Nova Laboratories Ireland
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Sister company established to continue supply of products to the EU following Brexit. Handles EU import testing and QP release before distribution within the EU community. Became operational in 2021.

novalabs.co.uk
Recent move12 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

UK-based CDMO specializing in sterile injectable fill-finish for clinical trials and small-batch commercial supply. Directly comparable as a UK-headquartered specialist in aseptic manufacturing and clinical trial material production.

TypeBroad incumbent
Description

Northern Ireland-headquartered global CDMO offering sterile manufacturing, clinical trial supply, and analytical services. Overlaps with Nova's contract manufacturing, clinical trial material, and analytical testing capabilities, but at significantly larger scale and broader geographic reach.

TypeDirect peer
Description

German-headquartered specialist CDMO focused on aseptic fill-finish of complex injectable biologics. Comparable in its deep specialization in sterile aseptic processing, complex formulation challenges, and regulatory-grade quality systems serving biopharma clients.

TypeBroad incumbent
Description

Global CDMO offering sterile fill-finish, clinical trial services, and specialty manufacturing. Comparable in sterile injectable manufacturing and clinical trial material supply, but operates at substantially larger scale and geographic breadth.

TypeDirect peer
Description

UK-based specialist CDMO focused on formulation development and clinical trial manufacturing, including sterile and aseptic processing. Comparable as a UK-headquartered emerging CDMO serving similar early-phase and niche commercial pharmaceutical clients.

TypeDirect peer
Description

UK-based CDMO providing API development, manufacturing, and contract services across small molecules and increasingly complex modalities. Comparable as a UK-headquartered mid-sized contract manufacturer serving pharmaceutical and biopharmaceutical clients.

TypeBroad incumbent
Description

Global CDMO with extensive sterile injectable fill-finish and biopharma capabilities, including gene therapy and cell therapy manufacturing. Comparable across Nova's aseptic manufacturing and novel modality offerings, but at a vastly larger global scale.

TypeDirect peer
Description

European CDMO with strong capabilities in complex injectables, peptides, and sterile manufacturing. Comparable in its specialization in complex aseptic formulations and contract manufacturing for pharmaceutical clients.

9Recipharm
TypeBroad incumbent
Description

European-headquartered CDMO offering sterile fill-finish, biologics, and contract manufacturing services. Comparable as a contract manufacturing peer in sterile injectable production, though at significantly larger scale and broader service portfolio.

TypeBroad incumbent
Description

Swiss-headquartered CDMO offering API and finished dose manufacturing including sterile injectable capabilities. Comparable as a European contract manufacturer with sterile production capabilities serving pharmaceutical clients.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Nova Laboratories

Sterile Pharmaceutical Manufacturingnovalabs.co.uk

Nova Laboratories firmographics

Firmographics
Name
Nova Laboratories
Legal name
Nova Laboratories Ltd
Website
https://novalabs.co.uk
Company type
Private
Founded year
1994
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

Nova Laboratories industry classification

Industry
Product category
Sterile Pharmaceutical Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (62151)
SIC
Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAGABAH
Sterile Fill-Finish & Aseptic Manufacturing CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAK
Clinical Trial Material (CTM) Manufacturing & Supply CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGAGAF
Analytical Development & QC Testing (Release/Stability/Potency)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAGADAC
Release Testing & Batch Certification (QC)
SECONDARYHLAAACAJ
Gene Therapy Vector Manufacturing & CDMO Services
Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)

Keywords

  • Sterile pharmaceutical manufacturing
  • Aseptic contract manufacturing
  • Specials medicines compounding
  • Drug stabilisation technologies
  • Specialty pharmaceutical products

Where Nova Laboratories is headquartered

Location

Headquarters

HQ city
Wigston
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Nova Laboratories business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Revenue model

  1. Contract Manufacturing Services: Provides contract sterile manufacturing, fill/finish, and 'Specials' manufacturing services to pharmaceutical, biopharmaceutical, and medical device companies. Includes 'turnkey' solutions with in-house analytical and microbiological testing, clinical trial labelling and packaging, and QP release.
  2. Nova Licensed Products: Develops, manufactures, and distributes Nova-branded medicines for niche and rare diseases with Marketing Authorisations in UK, EU, USA and ROW. Includes liquid versions of existing medicines for precision dosing and paediatrics.
  3. 'Specials' Medicines: Formulates, compounds, and packages bespoke 'Specials' medicines tailored to patients with clinically complex medical conditions. Supplies to NHS, healthcare providers, and veterinary sector.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels1 record

Nova Laboratories product offering

Product offering

Core offering

Nova Laboratories is a pharmaceutical manufacturer providing contract sterile manufacturing services (aseptic fill/finish, spray drying, clinical trial manufacturing) to pharmaceutical, biopharmaceutical and medical device companies, alongside its own Nova-branded licensed medicines for niche and rare diseases and bespoke 'Specials' compounding for individual patient needs. Its proprietary HydRIS® and VitRIS® platforms stabilise temperature-sensitive APIs, supported by in-house QC testing, microbiological services, clinical trial labelling/packaging and QP release.

Product overview

Nova Laboratories is a diversified pharmaceutical manufacturing company offering four interconnected service/product areas: Nova Licensed Products (proprietary branded medicines for niche and rare diseases), Sterile Manufacturing (contract aseptic manufacturing including fill/finish and spray drying), 'Specials' Manufacturing (bespoke medicines for individual patient needs), and Stabilisation Technologies (HydRIS® and VitRIS® platforms for temperature-sensitive products). The company operates as both a contract manufacturer and a product developer, with capabilities spanning from early-phase clinical trials through to commercial-scale production.

Differentiator

Problem solved

Functional benefit

Products and services

  • Nova Licensed Products Nova-branded medicines for the treatment of niche and rare diseases, including liquid versions of existing medicines for precision dosing and paediatrics, with Marketing Authorisations in the UK, EU, USA and ROW. Targeted at healthcare providers, community pharmacies, and patients with rare diseases.
  • Sterile Manufacturing (Contract Aseptic Manufacturing Services) Contract aseptic manufacturing services for pharmaceutical, biopharmaceutical and medical device companies, covering routine fill/finish from small hand-filled batches to semi-automated batches of up to 10,000 vials, spray drying, and processing of complex products including small molecules, peptides, proteins, antibodies, live biologicals, and gene therapies. Includes 'turnkey' solutions with in-house analytical and microbiological testing, clinical trial labelling and packaging, and QP release.
  • 'Specials' Manufacturing Bespoke 'Specials' medicines formulated, compounded, and packaged to the needs of patients with clinically complex medical conditions. Includes solutions, suspensions, mixtures, creams, ointments, lotions, capsules, suppositories, enemas, nasal drops, cytotoxic products, and controlled drugs. Supplied to NHS hospitals, healthcare providers, the veterinary sector, and via Nova Laboratories Ireland for EU customers.
  • HydRIS® Stabilisation Platform Proprietary Hypodermic Rehydration Injection System that dries a formulated solution or suspension of an unstable API around filaments of a small section of filter membrane to create ultra-thin sheaths and webs of dried, stabilised product, enabling dramatic increase in thermal stability with single-action reconstitution and injection. Used for low volume injectables including vaccines, live viral and bacterial products.
  • VitRIS® Stabilisation Platform Proprietary Vitrified Readily Injectable Suspension platform using aseptic spray drying to produce thermo-stable spherical particles of a formulated solution or suspension of an unstable API. Particles can be engineered to match the density of a non-aqueous injectable vehicle for stable suspension, addressing thermal instability and storage challenges for temperature-sensitive medicines.

Quantifiable outcome

  • Routine liquid fill/finish from small hand-filled batches to semi-automated batches of up to 10,000 vials
  • +3 more outcomes

Companies that use Nova Laboratories

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Nova Laboratories technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Nova Laboratories partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Nova Laboratories IrelandcoreStrategic or Co-development Partner · 1 January 2021Sister company established to continue supply of products to the EU following Brexit. Handles EU import testing and QP release before distribution within the EU community. Became operational in 2021.

Scale indicators6 records

Recent moves12 records

Expansion highlights5 records

Nova Laboratories competitors and assessment

Company assessment

Direct peers

  • Symbiosis Pharmaceutical Services: UK-based CDMO specializing in sterile injectable fill-finish for clinical trials and small-batch commercial supply. Directly comparable as a UK-headquartered specialist in aseptic manufacturing and clinical trial material production.
  • Vetter Pharma: German-headquartered specialist CDMO focused on aseptic fill-finish of complex injectable biologics. Comparable in its deep specialization in sterile aseptic processing, complex formulation challenges, and regulatory-grade quality systems serving biopharma clients.
  • Upperton Pharma Solutions: UK-based specialist CDMO focused on formulation development and clinical trial manufacturing, including sterile and aseptic processing. Comparable as a UK-headquartered emerging CDMO serving similar early-phase and niche commercial pharmaceutical clients.
  • Sterling Pharma Solutions: UK-based CDMO providing API development, manufacturing, and contract services across small molecules and increasingly complex modalities. Comparable as a UK-headquartered mid-sized contract manufacturer serving pharmaceutical and biopharmaceutical clients.
  • Corden Pharma: European CDMO with strong capabilities in complex injectables, peptides, and sterile manufacturing. Comparable in its specialization in complex aseptic formulations and contract manufacturing for pharmaceutical clients.

Broad incumbents

  • Almac Group: Northern Ireland-headquartered global CDMO offering sterile manufacturing, clinical trial supply, and analytical services. Overlaps with Nova's contract manufacturing, clinical trial material, and analytical testing capabilities, but at significantly larger scale and broader geographic reach.
  • PCI Pharma Services: Global CDMO offering sterile fill-finish, clinical trial services, and specialty manufacturing. Comparable in sterile injectable manufacturing and clinical trial material supply, but operates at substantially larger scale and geographic breadth.
  • Catalent: Global CDMO with extensive sterile injectable fill-finish and biopharma capabilities, including gene therapy and cell therapy manufacturing. Comparable across Nova's aseptic manufacturing and novel modality offerings, but at a vastly larger global scale.
  • Recipharm: European-headquartered CDMO offering sterile fill-finish, biologics, and contract manufacturing services. Comparable as a contract manufacturing peer in sterile injectable production, though at significantly larger scale and broader service portfolio.
  • Siegfried Holding: Swiss-headquartered CDMO offering API and finished dose manufacturing including sterile injectable capabilities. Comparable as a European contract manufacturer with sterile production capabilities serving pharmaceutical clients.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Nova Laboratories social profiles

Digital presence

Nova Laboratories financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Nova Laboratories leadership team

Management profile

Number of profiles

Profiles9 records

Nova Laboratories subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Nova Laboratories funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Nova Laboratories M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nova Laboratories

What does Nova Laboratories do?

Nova Laboratories is a pharmaceutical manufacturer providing contract sterile manufacturing services (aseptic fill/finish, spray drying, clinical trial manufacturing) to pharmaceutical, biopharmaceutical and medical device companies, alongside its own Nova-branded licensed medicines for niche and rare diseases and bespoke 'Specials' compounding for individual patient needs. Its proprietary HydRIS® and VitRIS® platforms stabilise temperature-sensitive APIs, supported by in-house QC testing, microbiological services, clinical trial labelling/packaging and QP release.

Is Nova Laboratories a public or private company?

Nova Laboratories is a private company. It is classified as family owned and is currently operating.

When was Nova Laboratories founded?

Nova Laboratories was founded in 1994. It employs 101 to 250 people.

Where is Nova Laboratories based?

Nova Laboratories is headquartered in Wigston, United Kingdom, in the Europe region.

How does Nova Laboratories make money?

Three revenue lines are on record. Contract Manufacturing Services are the primary driver. The others are nova Licensed Products and 'Specials' Medicines.

Who are Nova Laboratories's main competitors?

Direct peers on record are Symbiosis Pharmaceutical Services, Vetter Pharma, Upperton Pharma Solutions, Sterling Pharma Solutions and Corden Pharma. Broad incumbents are Almac Group, PCI Pharma Services, Catalent, Recipharm and Siegfried Holding.

Does Nova Laboratories have an API?

No public API is recorded for Nova Laboratories.

What industry is Nova Laboratories in?

Nova Laboratories's product category is Sterile Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAGABAH, Sterile Fill-Finish & Aseptic Manufacturing CDMO, with a secondary code of HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals